Replies to post #174592 on Biotech Values

[jq1234]

Interesting article on Teva from Bloomberg:

http://www.businessweek.com/news/2014-03-04/teva-returns-to-roots-after-outside-ceo-faces-nuthouse#p1

According to current and former executives, Levin wanted to buy a San Diego biotech called Receptos Inc. (RCPT:US) Several directors traveled to San Diego to assess the company, which would have cost Teva about $700 million, the executives said. In the end, the board said no.

RCPT would have been a good fit for them IMO.